This program will provide an examination of the current legal landscape surrounding access to GLP-1 drug products, including an analysis of the major players in the space and what we can expect moving forward. Alex Snyder is an associate at Quarles & Brady’s Health Law Group. Alex represents health care entities throughout the pharmaceutical space, […]